Refractive correction and patching improve VA in amblyopia

Article

Refractive correction and patching improves visual acuity in amblyopic eyes.

Refractive correction and patching improves visual acuity in amblyopic eyes, according to a paper in the Archives of Ophthalmology.

Dr Yi Pang et al., Illinois College of Optometry, Chicago, Illinois, USA, looked at 17 amblyopic children. The patients were aged between 4 and 14 years and has amblyopia linked to myopic anisometropia.

Visual acuity (VA) was evaluated at 4, 8, 12 and 16 weeks whilst all patients wore spectacles and/or contact lenses for complete refractive correction. At 16 weeks all patients underwent patching.

Mean baseline VA in amblyopic eyes improved from 0.96 logMAR to 0.84 logMAR with refractive correction and a mean of 0.71 logMAR with additional patching. The findings demonstrated an improvement of 2.59 lines when comparing baseline VA and final VA.

Final VA was linked to baseline VA, magnitude of anisometropia and the patching compliance level. The improvement in VA was linked to patient age and presence of eccentric fixation.

Overall, 88% of patients experienced an improvement of 2 lines or more and a further improvement was discovered when patching was applied to patients who underwent refractive correction.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.